Europe Organ Preservation Solution Market Forecast to 2031 - Regional Analysis - by Product, Application, Type, and End User

The Europe organ preservation solution market was valued at US$ 86.52 million in 2023 and is expected to reach US$ 1,59,990.22 thousand by 2031; it is estimated to register a CAGR of 8.1% from 2024 to 2031.

Increasing Prevalence of Chronic Disease Fuels Europe Organ Preservation Solution Market

Chronic diseases, which may be congenital or acquired, can lead to gradual damage to organs over time. A chronic disease typically does not resolve on its own, but there may be ways to slow down the damage caused by the condition. It may take decades for this damage to build up to the point where it noticeably affects patients' organ function or requires medical intervention. Chronic kidney disease (CKD) is a common and potentially fatal condition that affects approximately 1 in every 10 people worldwide. Chronic liver diseases such as fatty liver disease and hepatitis C are the common causes of chronic liver failure. The World Health Organization (WHO) estimates that ~50 million people are living with chronic hepatitis C virus infection worldwide, with approximately 1.0 million new infections occurring each year. In 2022, ~242,000 people died from hepatitis C, mainly due to cirrhosis and hepatocellular carcinoma. Chronic heart diseases, including coronary artery disease and congenital heart disease, can lead to progressive heart failure. According to the Global Heart & Circulatory Diseases Factsheet by the British Heart Foundation, congenital heart disease is a rapidly emerging problem in child health worldwide. It is diagnosed in approximately 1 in 110 births globally, and the diagnoses later in the lives of babies may reach as high as 1.2 million per year, averaging 3,300 per day (or a diagnosis every 26 seconds). Thus, the demand for organ preservation solutions increases with a surge in the need for availability of chronic disease-related organ transplantation procedures.

Europe Organ Preservation Solution Market Overview

The Europe organ preservation solution market is segmented into Germany, France, the UK, Spain, Italy, and the Rest of Europe. Germany and Italy are expected to account for a significant market share in the regional market during the forecast period. The market in France, the UK, and Spain is likely to experience lucrative opportunities in the coming years. The growing number of organ transplantations, rising prevalence of chronic diseases that lead to organ failure, and technological advancements in organ preservation solutions drive the organ preservation solution market growth in Europe. Germany is expected to be among the major contributors to the growth of the organ preservation solution market in worldwide. As per the "World Population Ageing," nearly 28.0% of the total population of Germany was aged 60 and above in 2017, and the aging population is estimated to rise to nearly 37.6% by 2050. The prevalence of chronic diseases increases with age. Also, with growing age, many organs start to malfunction or become dysfunctional, giving rise to the demand for organ transplantation procedures. Thus, with the rising geriatric population, the demand for organ preservation solutions is growing.

Europe Organ Preservation Solution Market Segmentation

The Europe organ preservation solution market is categorized into product, application, type, end user, and country.

Based on product, the Europe organ preservation solution market is categorized into University of Wisconsin solution, custodiol HTK, Perfadex, HypoThermosol, and others. The University of Wisconsin segment held the largest market share in 2023.

In terms of application, the Europe organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest market share in 2023.

By type, the Europe organ preservation solution market is categorized into kidneys, liver, lungs, heart, and others. The kidneys segment held the largest market share in 2023.

Based on end user, the Europe organ preservation solution market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment held the largest market share in 2023.

By country, the Europe organ preservation solution market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe organ preservation solution market share in 2023.

XVIVO Perfusion, TransMedics, OrganOx Limited, Paragonix Technologies, Inc, Dr. Franz Koehler Chemie GmbH, and Accord Healthcare, are among the leading companies operating in the Europe organ preservation solution market.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe organ preservation solution market.
• Highlights key business priorities to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Europe organ preservation solution market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe organ preservation solution market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.